Details for New Drug Application (NDA): 087193
✉ Email this page to a colleague
NDA 087193 describes SOMOPHYLLIN-CRT, which is a drug marketed by Graham Dm and is included in five NDAs. Additional details are available on the SOMOPHYLLIN-CRT profile page.
The generic ingredient in SOMOPHYLLIN-CRT is theophylline. There are thirty-six drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the theophylline profile page.
The generic ingredient in SOMOPHYLLIN-CRT is theophylline. There are thirty-six drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the theophylline profile page.
Summary for 087193
| Tradename: | SOMOPHYLLIN-CRT |
| Applicant: | Graham Dm |
| Ingredient: | theophylline |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 087193
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE, EXTENDED RELEASE;ORAL | Strength | 250MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
